Telomerase RNA as a detection marker in the serum of breast cancer patients

Clinical Cancer Research

Volumn 6, Issue 10, 2000, Pages 3823-3826

  Qi Chen, Xu ^a   Bonnefoi, Hervé ^b   Pelte, Marie Françoise ^c   Lyautey, Jacqueline ^a   Lederrey, Christine ^a   Movarekhi, Sina ^b   Schaeffer, Pierre ^b   Mulcahy, Hugh E ^d   Meyer, Pierre ^e   Stroun, Maurice ^a   Anker, Philippe ^a  

^a Faculte des Sciences   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Université   (Switzerland)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e LA TOUR HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; RNA; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033760396     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Long-term cancer patient survival in the United States
2. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69
3. Lessons from the mammography screening controversy: Can we improve the debate?
4. Ten- to fourteen-year effects of breast cancer on mortality
5. The Swedish randomised mammography screening trials: Analysis of their effect on the breast cancer related excess mortality
6. Efficacy of screening mammography. A meta-analysis
7. Benefit of mammography screening in women aged 40 to 49 years: Current evidence from randomized controlled trials
8. Screening mammography and public health policy: The need for perspective
9. Psychological cost of screening
10. Benefits and costs of screening and treatment for early breast cancer
11. The debate over mass mammography: Is it beneficial for women?
12. Presence of tumor DNA in plasma of breast cancer patients: Clinicopathological correlations
13. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer
14. Microsatellite abnormalities in plasma of patients with breast carcinoma: Concordance with the primary tumour
15. Microsatellite alterations plasma DNA of primary breast cancer patients
16. TP53 gene mutations in plasma DNA of cancer patients
17. Aberrant DNA methylation of the p16(INK4a) gene in plasma DNA of breast cancer patients
18. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients
19. Nucleic acid concentrations in normal human plasma
20. A gene probe test for serum RNA proteolipid in neoplasia
21. Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: First clinical evaluation of a novel tumor marker
22. Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans
23. Detection of tumor messenger RNA in the serum of patients with malignant melanoma
24. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma
25. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue
26. Differential telomerase activity. Expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors
27. Expression of hTERT and hTR in cis reconstitutes and active human telomerase ribonucleoprotein
28. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors
29. Telomerase activation by hTR in human normal fibroblasts and hepatocellular carcinomas
30. A survey of telomerase activity in human cancer
31. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: Correlation with grade, histology, and proliferative activity